Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro-Reference-Cited by-同舟云学术

Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro

Published:2019-01 Issue:1 Volume:37 Page:80-89
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Queenan Anne Marie,Dowling David J.,Cheng Wing Ki,Faé Kellen,Fernandez Jeffrey,Flynn Peter J.,Joshi Sweta,Brightman Spencer E.,Ramirez Juan,Serroyen Jan,Wiertsema Selma,Fortanier Alexandre,van den Dobbelsteen Germie,Levy Ofer,Poolman Jan

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge;Burns;J Infect Dis,2014

2. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology;Sheridan;Exp Rev Vaccines,2014

3. Waning immunity and microbial vaccines-workshop of the national institute of allergy and infectious diseases;Gu;Clin Vaccine Immunol,2017

4. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines;Hegerle;Exp Rev Vaccines,2014

5. Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies;Rodriguez;FEMS Immunol Med Microbiol,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations;Clinical Microbiology Reviews;2023-09-21

2. Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model;Vaccines;2023-04-28

3. Pertussis Vaccines;Plotkin's Vaccines;2023

4. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination;Scientific Reports;2022-10-18

5. Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines;Vaccines;2021-08-07